Fundraising FoxWormhole Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis.
AI & Machine LearningBiotechHealthtechMedical DevicesTel Aviv, IL
Edmund Ben-Ami(Founder)inEdmund Benami(Founder)Gil Shklarski(Founder)in
BoardProf. Thomas SüdhofProf. Olivier Rascol
Co-investorsMS&AD VenturesAlumni VenturesBreyer CapitalKoch Disruptive TechnologiesSamsung NextVSC Ventures+3 more
Thyme Care develops software to enhance care coordination and outcomes for cancer patients.
Digital HealthHealthtechNashville, US
Robin Shah(Executive Officer, Director)inBobby Green(Founder)in
BoardBrian Belsky(Director)inElizabeth Canis(Director)inBrenton Fargnoli(Director)inVineeta Agarwala(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCorewell Health VenturesCVS Health VenturesEcho Health VenturesForesite Capital+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.